| Value | ₹929.2 Cr |
|---|
NSE filing, NSE: LLOYDSENT. Summary written from the filing by ALFA Finder's alert engine.
Lloyds Enterprises Ltd: key numbers
- Share price
- ₹60.98
- Market cap
- ₹9,309 Cr
- Revenue (annual)
- ₹1,756 Cr
- Net profit (annual)
- ₹283.4 Cr
- P/E (TTM)
- 82.9×Sector 45.0×
- Promoter holding
- 62.71%-0.01% QoQ
- FII holding
- 0.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lloyds Enterprises Ltd
All →Lloyds Enterprises Other Announcement
Lloyds Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Lloyds Enterprises Employee Stock Options
Lloyds Enterprises granted 1,35,440 ESOPs under its 2025 plan at Rs. 2 per option. Options carry a one-year minimum vesting and three-year exercise window.
Lloyds Enterprises Price Movement Clarification
Lloyds Enterprises Limited clarified that the recent increase in share trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information at this time.
Lloyds Enterprises Debt & Borrowing: ₹40 Cr
Lloyds Enterprises Limited informed that Tata Capital Limited assigned a portion of its loan facility, amounting to ₹40 Crore, to Aditya Birla Capital Limited.
- Value
- ₹40.00 Cr
Lloyds Enterprises Legal & Regulatory
Lloyds Enterprises settled SEBI enforcement proceedings related to a 2025 show-cause notice. The company paid a combined settlement amount of Rs. 4.16 Crore.
- Value
- ₹4.16 Cr
Lloyds Enterprises Legal & Regulatory
Lloyds Enterprises Limited settled enforcement proceedings with SEBI regarding alleged violations of PFUTP and LODR regulations. The settlement order disposes of the show-cause notice without financial impact.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.